flutamide has been researched along with 5-alpha-dihydroprogesterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toombs, AR; Wiren, KM; Zhang, XW | 1 |
| Blair, JM; Jackson, P; Rowe, A; Russell, PJ; Vandyke, K | 1 |
2 other study(ies) available for flutamide and 5-alpha-dihydroprogesterone
| Article | Year |
|---|---|
Androgen inhibition of MAP kinase pathway and Elk-1 activation in proliferating osteoblasts.
Topics: 5-alpha-Dihydroprogesterone; Androgen Receptor Antagonists; Androgens; Animals; Cell Division; Cell Survival; DNA-Binding Proteins; ets-Domain Protein Elk-1; Extracellular Signal-Regulated MAP Kinases; Flutamide; Genes, Reporter; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Oligonucleotide Array Sequence Analysis; Osteoblasts; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Receptors, Androgen; Transcription Factors; Tumor Cells, Cultured | 2004 |
Androgen decreases osteoprotegerin expression in prostate cancer cells.
Topics: 5-alpha-Dihydroprogesterone; Androgens; Cell Line, Tumor; Flutamide; Gene Expression; Humans; Male; Osteoprotegerin; Prostatic Neoplasms; RNA, Messenger | 2007 |